In addition, pharmacological inhibitor (GSK’547) of RIP1 was demonstrated to alter the phenotype of TAMs from immunosuppressive to immunogenic (MHCIIhiTNFα+IFNγ+) with significant reduction in tumor burden and metastasis. The gene discussed is IFNG; the disease is neoplasm.